The list below is a sampling of the many open BMT clinical trials at University of Minnesota Medical Center. Click on the highlighted links below for a printable pdf summary of selected studies. We will be adding new summaries in the future, so please be sure to visit us again. For information on additional trials, please call 612-273-2800.

Hodgkin’s Lymphoma

Reduced Intensity UCB Transplant (MT2005-02)
  
Reduced Intensity Allo Bone Marrow Transplant (2001-10)

Unrelated or Partially Matched Related Donor Transplant for Lymphoma, Myeloma, & CLL (MT 1999-14)

Allo Transplant for Heme Malignancy (MT 2001-02)

UCB Tregs after Reduced Intensity Transplant (MT 2006-01)

Reduced Intensity UCB Transplant with C3a Priming (MT 2008-15)

Tac/Sivo/Mtx vs. Tac/Mtx or CSA/MMF after Reduced Intensity Allo Transplant for Lymphoma (MT 2009-16)

Autologous Peripheral Blood Stem Cell Transplant for HIV-Associated Lymphoma (MT 2004-24)

Non-Hodgkin’s Lymphoma

Reduced Intensity Allo Bone Marrow Transplant (2001-10)

Reduced Intensity Allo Transplant for Relapsed Follicular NHL (MT2008-42)

Reduced Intensity UCB Transplant (MT2005-02)
    
Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)

Unrelated or Partially Matched Related Donor Transplant for Lymphoma, Myeloma, & CLL (MT1999-14)

Expanded Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT2008-38)

Allo Transplant for Heme Malignancy (MT 2001-02)

UCB Tregs after Reduced Intensity Transplant (MT 2006-01)

Reduced Intensity UCB Transplant with C3a Priming (MT 2008-15)

Non-Myeloablative Conditioning with Pentostatin, Rituximab and Ontek plus NK cells for Refractory NHL & CLL (MT 2009-15)

Tac/Sivo/Mtx vs. Tac/Mtx or CSA/MMF after Reduced Intensity ALlo Transplant for Lymphoma (MT 2009-16)

Autologous Peripheral Blood Stem Cell Transplant for HIV-Associated Lymphoma (MT 2004-24)